These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy. Hendley ED, Snyder SH. Nature; 1968 Dec 28; 220(5174):1330-1. PubMed ID: 5701350 [No Abstract] [Full Text] [Related]
6. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases. Abdel Samed MH, Akopyan ZI, Veryovkina IV, Kulygina AA, Gorkin VZ. Biochem Pharmacol; 1971 Oct 28; 20(10):2571-7. PubMed ID: 5114498 [No Abstract] [Full Text] [Related]
7. A simple fluorometric assay for type B monoamine oxidase activity in rat tissues. Suzuki O, Noguchi E, Yagi K. J Biochem; 1976 Jun 28; 79(6):1297-9. PubMed ID: 956156 [Abstract] [Full Text] [Related]
8. The mechanism of action of the monoamine oxidase inhibitor pargyline. Oreland L, Kinemuchi H, Yoo BY. Life Sci; 1973 Dec 01; 13(11):1533-41. PubMed ID: 4797641 [No Abstract] [Full Text] [Related]
9. Letter: Monoamine tetrazolium reductase of rat heart mitochondria. Sen R, Parmar SS, Guha SR. J Pharm Pharmacol; 1973 Oct 01; 25(10):835-7. PubMed ID: 4149751 [No Abstract] [Full Text] [Related]
10. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns. Collins GG, Youdim MB, Sandler M. Biochem Pharmacol; 1972 Jul 15; 21(14):1995-8. PubMed ID: 4405452 [No Abstract] [Full Text] [Related]
11. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Robinson DS, Lovenberg W, Keiser H, Sjoerdsma A. Biochem Pharmacol; 1968 Jan 15; 17(1):109-19. PubMed ID: 4384242 [No Abstract] [Full Text] [Related]
12. Inhibition of the formation of tetrahydroisoquinoline alkaloids in brain homogenates. Alivisatos SG, Ungar F, Callaghan OH, Levitt LP, Tabakoff B. Can J Biochem; 1973 Jan 15; 51(1):28-38. PubMed ID: 4689093 [No Abstract] [Full Text] [Related]
15. Effects of 1-(indolyl-2-carbonyl)-2-alkyl-hydrazine derivatives on amine levels and monoamine oxidase activity in rat tissues. Vega P, Borrell S. Biochem Pharmacol; 1972 Oct 01; 21(19):2571-5. PubMed ID: 4661618 [No Abstract] [Full Text] [Related]
16. [New data on monoamine oxidase inhibitors]. Gorkin VZ. Vestn Akad Med Nauk SSSR; 1971 Oct 01; 26(11):23-8. PubMed ID: 4942003 [No Abstract] [Full Text] [Related]
17. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines. Popov N, Matthies H, Lietz W, Thiemann C, Jassmann E. Biochem Pharmacol; 1970 Aug 01; 19(8):2413-8. PubMed ID: 5520601 [No Abstract] [Full Text] [Related]
18. The metabolism of betahistine in the rat. Sternson LA, Tobia AJ, Walsh GM, Sternson AW. Drug Metab Dispos; 1974 Aug 01; 2(2):123-8. PubMed ID: 4150992 [No Abstract] [Full Text] [Related]
19. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum. Philips SR, Boulton AA. J Neurochem; 1979 Jul 01; 33(1):159-67. PubMed ID: 572413 [No Abstract] [Full Text] [Related]
20. Monoamine oxidase inhibition and recovery in the mouse brain at various ages after birth. Samsa JM, Baker PC, Hoff KM. Biol Neonate; 1979 Jul 01; 35(5-6):249-54. PubMed ID: 476197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]